Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
SCYNEXIS Inc
SCYX
Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,...
such as Candida and Aspergillus genera, including multidrug-resistant strains, and Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and common mucorales species. Ibrexafungerp is the first representative of this novel class of antifungals with additional assets from the fungerp family, including SCY-247, in preclinical stages of development. The United States Food and Drug Administration approved BREXAFEMME for treatment of patients with vulvovaginal candidiasis, also known as vaginal yeast infection, and for the reduction in the incidence of recurrent vulvovaginal candidiasis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SCYX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(8)
•••
gisellekronk
X
View Profile
View Bullboard History
Post by
gisellekronk
on Feb 19, 2020 1:19pm
up ten cents
woo hoo , the start of something or just more dissapointment ?
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on Jan 08, 2020 12:46pm
good news
sadly it is used only to recover lost ground .
Silvercorp to Acquire Adventus, Creating a Diversified Mining Company
posted May 02, 2024 9:00am by
Adventus Mining Corp.
-
|
Under the terms of the Arrangement Agreement, each holder of the common shares of Adventus will receive 0.1015 of one Silvercorp common share in exchange for each Adventus Share at the effective time of the Transaction. The Exchange Ratio implies consideration of C$0.50 per Adventus Share ...read more
(8)
•••
gisellekronk
X
View Profile
View Bullboard History
Post by
gisellekronk
on Dec 23, 2019 6:53am
they like us
Hedge Fund Armistice Capital Reports 5.7% Stake in Scynexis
(8)
•••
gisellekronk
X
View Profile
View Bullboard History
Post by
gisellekronk
on Dec 10, 2019 11:54am
down
SCYNEXIS Prices $35 Million Offering of Common Stock, Warrants .. this stock is no different from holding junior gold miners . unless they strick it big , you wont make any money .
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on Nov 04, 2019 10:01am
finally
selling pressure is off
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on Aug 17, 2019 9:14am
Scyx against superbug
The drug-resistant fungus, Candida auris, was only discovered 10 years ago, but is now one of the world's most feared hospital microbes. These infections are usually quite serious. Around
...more
(8)
•••
gisellekronk
X
View Profile
View Bullboard History
Comment by
gisellekronk
on Aug 08, 2019 11:34am
RE:cure worse than the disease
``they should invent a product to kill off the molds attracking this stock `` , good one , lol
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on Aug 02, 2019 2:03pm
cure worse than the disease
instead of treating fungi they should invent a product to kill off the molds attracking this stock . hedgefunds and all other parasites feasting on companies weaknesses . do thay have a miracle
...more
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on May 22, 2019 11:54am
going to the dogs
it was not to be
(219)
•••
Tcheck
X
View Profile
View Bullboard History
Post by
Tcheck
on May 01, 2019 10:12am
a company worth supporting
May 1 (Reuters) - SCYNEXIS Inc : * SCYNEXIS TO PRESENT DATA AT ACOG 2019 FURTHER DEMONSTRATING THE FAVORABLE PROFILE OF IBREXAFUNGERP FOR THE TREATMENT OF VULVOVAGINAL CANDIDIASIS (VVC)
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results